Vor Biopharma Inc.

AI Score

0

Unlock

0.97
-0.11 (-10.19%)
At close: Mar 03, 2025, 3:59 PM
0.95
-2.14%
After-hours: Mar 03, 2025, 04:00 PM EST

Vor Biopharma Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -1.28 -2.9 -6.28 -32.13 -121.6 -51.12
PEG Ratio 0.05 -0.12 -0.11 -0.12 2.11 n/a
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio 1.00 1.05 2.00 28.84 182.20 -31.37
P/FCF Ratio -1.49 -2.81 -5.91 -34.42 -131.28 -79.77
P/OCF Ratio -1.51 -3.09 -6.25 -38.36 -141.25 -79.77
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.24 0.16 0.08 0.38 n/a -0.66
Quick Ratio 9.04 18.06 21.12 4.81 3.45 0.12
Current Ratio 9.04 18.06 21.12 4.81 3.45 0.12
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage n/a n/a n/a n/a -17.13 -2.85
Return on Equity (ROE) -0.78 -0.36 -0.32 -0.9 -1.5 0.61
Return on Assets (ROA) -0.59 -0.3 -0.28 -0.57 -1.16 -4.12
Return on Capital (ROIC) -0.69 -0.33 -0.3 -0.66 -1.36 0.42
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a